A framework model for a contextualized and integrated warfarin therapy case in a master of pharmacy program by Fergus, Suzanne et al.
RESEARCH
A Framework Model for a Contextualized and Integrated Warfarin Therapy
Case in a Master of Pharmacy Program
Suzanne Fergus, PhD, MA, Amandeep Birdi, MPharm, Farakh Riaz, MPharm
School of Life and Medical Sciences, University of Hertfordshire, Hertfordshire, United Kingdom
Submitted August 1, 2017; accepted March 7, 2018; published June 2019.
Objective. To develop and integrate a case study on warfarin into a clinical pharmacy workshop.
Methods. A framework model was designed and used to create a case study on warfarin therapy. The
case study was implemented in a third-year Master of Pharmacy course. Student feedback was obtained
using an online questionnaire and two focus groups.
Results. All students agreed that the case study successfully integrated the science of warfarin and
concepts of pharmacy practice. The majority of students (94%) agreed that this approach helped them
to understand the science of warfarin more than a traditional lecture would have. Students felt the time
allocated to the workshop was too short.
Conclusion. An integrated case study provides a learning environment that emphasizes the contextu-
alization of chemistry and pharmacology into a clinical pharmacy setting.
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INTRODUCTION
Patient safety lies at the core of the pharmacy pro-
fession. Pharmacists have a central role inmaintaining the
health, safety, and wellbeing of patients. Because of the
narrow therapeutic window of warfarin, pharmacists play
a key role in the management of patients for whom the
drug is prescribed. The risks of adverse drug reactions that
can occur with warfarin are high because of the numerous
potential food and drug interactions.1 Thus, it is vital for
pharmacists to have and be able to use their scientific
knowledge in this area. A key focus of pharmacy educa-
tion is to integrate scientific principles into the curriculum
that underpin effective pharmacy practice. This article
outlines a framework developed and then used to design
an integrated clinical case study for warfarin treatment.
The case study was used to test students’ comprehension
of the material and ability to apply scientific principles in
pharmacy practice.
The United Kingdom’s General Pharmaceutical
Council (GPhC) has emphasized in their educational stan-
dards for accredited Master of Pharmacy (MPharm) de-
gree programs that “sound science is the basis of effective
pharmacy.”2 Integration is also emphasized by the Center
for Advancement of Pharmacy Education (CAPE)3 and
the Accreditation Council for Pharmacy Education
(ACPE) standards for Doctor of Pharmacy (PharmD) de-
gree programs with assessment outcomes that “reflect
mastery of the sciences and their integration in pharmacy
practice.”4 This discipline integration approach in phar-
macy education has been highlighted as one of the leading
strategies in teaching pharmacy practice.5
There is a clear shift in pharmacy education from
placing the responsibility solely on students to make con-
nections that link different disciplines to implementing
curriculum design that facilitates an integrative approach
to learning. Curricular integration in pharmacy education
includes horizontal integration crossing discipline bound-
aries and vertical integration connecting across time and
between theory and practice.6 This includes Harden’s
ladder of integration where multidisciplinary (separate
disciplines focusing on a common theme), interdisciplin-
ary (disciplines developing a shared understanding of a
topic), and transdisciplinary (disciplinary distinctions not
evident) form part of a gradated scale for curriculum in-
tegration.7 There is no single preferred integration strat-
egy when dealing with a complex curriculum.
The use of real-life applications to introduce or con-
textualize the study of a scientific concept is an example
of vertical integration and is especially important in phar-
macy education in order to translate safe and effective
practice from the classroom to the clinical setting.
Previous research has described contrasting methods of
contextualization, some of which have incorporated sim-
ulated or virtual patients. For example, the Pharmville’
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project developed a fictional community of people to
augment learning in an undergraduate pharmacy pro-
gram. Through this virtual experience, students could
explicitly see the link between the chemistry of drugs
and the people who actually used them.8 A three-week
course that integrated relevant pharmaceutical and clin-
ical sciences through a combination of lectures, case
studies, and other teaching methods demonstrated high
pass rates on assessments. Furthermore, students found
the integration “very or extremely” relevant in terms of
application of basic sciences in clinical knowledge com-
pared to the traditional approach to learning.9 Other suc-
cessful integrated approaches to teaching clinical
pharmacy include team-based learning a task-based
learning exercise involving a simulated drug discovery
activity and team-based case study exercises.10-12 A flip-
ped classroom model using vodcasts (video podcasts)
prior to in-class discussions of interactive case stud-
ies of patients with end-stage renal disease resulted
in significant improvement in students’ examination
performance.13 Case-based integration in a medicinal
chemistry and pharmacotherapy course facilitated more
active participation from students in the learning and
evaluation process.14 Not surprisingly, the case study
approach features strongly in the examples of integration
as it provides scenarios that students are likely to en-
counter in professional practice. Students are challenged
to explore their existing preconceptions and modify
them to accommodate the realities of the case studies.
The scenarios presented tend to be rich in contextual
details, which requires students to apply material with
which they are already somewhat familiar.15
The positive impact of using case studies is well
documented. An extensive review from Bennett and col-
leagues of 17 experimental studies undertaken in eight
different countries on the effects of context-based ap-
proaches, including case studies, to science teaching in
secondary schools found that context-based approaches
resulted in improved attitudes to science among students
because the science was made relevant to their lives and
possible future careers.16 Currie and colleagues reported
that small, group workshops requiring students to work
through integrated medicinal chemistry cases improved
student attitudes towards science as the cases studies
allowed them to avoid the tedious task of simply memo-
rizing structures and drug interactions.17
Despite the effective outcomes and implementation
of contextualized case studies, there is little evidence or
guidance in the literature regarding the construction of
integrated case studies. The investigators wished to de-
velop a suitable framework model in order to create an
integrated pharmacy case study, and we selected warfarin
to be the exemplar. The case study aims to move students
towards application and critical analysis of scientific con-
cepts that underpin safe and effective pharmacy practice.
The purpose of this study was to examine the effective-
ness of an integrated science and pharmacy practice case
study on warfarin. Two research questions informed the
study in relation to developing a suitable framework for
generating integrated pharmacy case studies and the stu-
dent experience when using an integrated pharmacy case
study in a classroom setting.
METHODS
Following an in-depth analysis of previous case stud-
ies, common featureswere identified and categorized into
five stages for creating an effective case study as dis-
cussed below (Figure 1).12,17,18
The first stage in developing an effective case study
involves choosing a pharmacy-related setting. Generally,
contextualized case studies in pharmacy education are set
within a pharmacy workplace. We chose a community
pharmacy as the setting for this case study.
The second stage is creating a fictional patient. Fic-
tional patients are commonly used as a platform to illus-
trate the science and pharmacy practice of a medicine.
This is normally done by creating a narrative involving
a patient, stating the condition, and indicating the medi-
cine treatment used. The fictional patient used in the case
study detailed here is male, 62 years old, and receiving
warfarin therapy for deep vein thrombosis (DVT). Other
factors beyond the medication involved may be signifi-
cant in the therapeutic outcome, eg, lifestyle factors,
which are discussed under other relevant information.
The problem or dilemma presented in case studies
usually involves destabilization of the patient’s drug ther-
apy. This supports the development of pharmacy stu-
dents’ higher-order thinking as the context requires
Figure 1. Framework for an Integrated Pharmacy Case Study
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analysis and evaluation rather than simple recollection of
facts. As warfarin is the chosen therapy in this case study,
the problem selected for the patient was hemorrhage.
Hemorrhage, more commonly known as bleeding is the
main adverse effect of warfarin. From a meta-analysis of
33 studies, major and fatal bleeding events occur respec-
tively at rates of 7.2 and 1.3 per 100 patient-years.19
The fourth stage in creating the case study was to
decide what the causative factors would be. In order to
demonstrate the role of the pharmacist in reporting war-
farin’smain adverse drug reactions (ADRs), we needed to
include some causative factors for the patient’s bleeding
to have occurred. These causative factors would then be
used to demonstrate how the application of science un-
derpins effective pharmacy practice.
Warfarin is metabolized by the cytochrome P450
(CYP) enzyme system.20 The pharmacist must therefore
ensure if a patient were to take another medication, it
would not inhibit or induce the CYP enzymes. If the
CYP enzymes were induced or inhibited by another med-
ication, warfarin’s metabolism would be significantly af-
fected. 20
The fictional patient in this case study explains to the
pharmacist that he started antibiotic treatment with met-
ronidazole two days before coming into the community
pharmacy. Metronidazole inhibits the CYP enzyme sys-
tem, reducing warfarin’s metabolism in the body.21 This
enhances the anticoagulant effect of warfarin, which led
to the patient’s uncontrolled warfarin therapy and, conse-
quently, hemorrhaging.
The causative factor presented here is the interaction
of the antibiotic metronidazole with warfarin. Without an
understanding of the science of warfarin, specifically its
metabolism in the body and the enzyme systems involved,
a pharmacist cannot analyse and comprehend the patient
safety implications.
The fifth stage in developing the case study was in-
clusion of other relevant information. Details regarding
changes to the patient’s living arrangements and diet were
clarified. However, it was also important to consider the
extent of additional information included. The resulting
cognitive overload caused by the “noise” of additional
information in the case study could have negatively af-
fected field dependent learners. 2
Guided by this framework, we developed the case
study focusing on warfarin therapy (Figure 1). Once the
first draft of the integrated case study was completed, a
professor of pharmaceutical chemistry and a professional
lead instructor in clinical pharmacy reviewed it. The in-
tegrated case study was then piloted with final year
MPharm students to assess its difficulty and ensure
undergraduate students could understand it clearly. Their
feedback indicated that the case study did not clarify
whether the patient was on any other medication. As a re-
sult, the case study was reworded to clarify that the patient
was not taking any othermedication exceptmetronidazole.
The integrated warfarin case study was presented
to approximately 165 third-year MPharm students in a
one-hour workshop as part of the Drug Discovery and
Development module. Third-year students had covered
the fundamental scientific and pharmaceutical principles
related to warfarin in previous years, and this knowledge
base would enable them to evaluate the effectiveness of
an integrated case study comparing this strategy to their
other learning approaches.
The outcome levels for the case study and associated
questions were derived from Miller’s competence and
assessment hierarchy (Figure 2) and Bloom’s taxon-
omy.23,24 Miller’s pyramid illustrates the assessment of
clinical skills and competence where each underlying
level is the building block for the next level. We expect
students to demonstrate not only that they “know” the
theory that underpins clinical practice, but that they
“know how” to apply this knowledge and “show how”
that they can translate this learning to a suitable context.
The overall learning goal for the integrated warfarin
case study was for students to apply basic scientific prin-
ciples and determine how each causative factor could
have led to the patient’s hemorrhaging. A three-step, pro-
gressive question model (Figure 3) was adopted to scaf-
fold the assessment design and support the students in
meeting this learning goal. Part A of each question re-
quired students to revisit a familiar scientific concept. Part
B required students to understand and relate the scientific
concept from part A to pharmacy practice (ie, the “know
Figure 2. Framework for Clinical Assessment 23
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how” stage on Miller’s Triangle). Part C further explored
how both answers apply to the case study patient, and to
“show how” they would use this information in a simu-
lated environment.
Students were required to attend one workshop ses-
sion altogether. Ideally, we hoped to have the cohort split
into smaller, separate groups to encourage collaborative
group discussions. However, the resources to do this were
not available. The academic instructor presented students
with the integrated case study questions sequentially dur-
ing the workshop and then allowed time for small group
discussions.
The learning outcomes for the integrated case
study were aligned with the GPhC Standard 10 outcomes
“Future pharmacists: Standards for the initial education
and training of pharmacists.”2 How each question met
the expectations of an MPharm student and also a pre-
registration pharmacist is shown in Table 1.
Ethical considerations with support from the
MPharm Program Lead were conducted under University
ofHertfordshire EthicalGuidelines.All student data sour-
ces were anonymized and the confidentiality of partici-
pants was ensured throughout dissemination of the
research data.
Prior to the workshop, students were required to pre-
pare responses to three background questions. These were:
“Explain INR.” “What is the main adverse effect of war-
farin?” and “Why does warfarin interact with so many
Figure 3. Three-step Progressive Assessment Model Based on Miller’s Triangle and Bloom’s Taxonomy
Table 1. Expected Learning Outcomes Using an Integrated Warfarin Case Study and the Professional Expectations of a Pharmacist
Outcomes MPharm Level Preregistration Level
Demonstrate how the science of pharmacy is applied in the design and
development of medicines and devices
Shows how Knows how
Respond appropriately to medical emergencies, including provision of first aid Knows how Shows how
Collaborate with patients, the public and other health care professionals to
improve patient outcomes
Knows how Shows how
Identify inappropriate health behaviours and recommend suitable approaches
to interventions
Shows how Does
Instruct patients in the safe and effective use of their medicines and devices Shows how Does
Provide, monitor and modify prescribed treatment to maximize health
outcomes
Shows how Does
Communicate with patients about their prescribed treatment Shows how Does
Record, maintain and store patient data Shows how Does
Establish and maintain patient relationships while identifying patients’ desired
health outcomes and priorities
Shows how Does
Obtain and record relevant patient medical, social and family history Shows how Does
Communicate information about available options in a way which promotes
health understanding
Shows how Does
Conclude consultation to ensure a satisfactory outcome Shows how Does
Demonstrate the characteristics of a prospective professional pharmacist as set
out in relevant codes of conduct and behaviour
Does Does
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drugs?” Questions 1 and 2 provided students with the nec-
essary background information needed for the workshop
session, and question 3 encouraged initial thinking about
the pharmaceutical science of warfarin covered in the case
study. Students were required to answer five additional
questions during the session (Appendix 1).
To evaluate student perceptions of this integrated
case study instructional design, an online questionnaire
and student focus groups were employed. The question-
naire consisted of 14 statements using a four-point Likert
scale (Appendix 2) and was piloted with a focus group of
fourth-year MPharm students.
The questionnaire was administered using an online
survey tool (Survey Monkey, San Mateo, CA). Students
from the third year were emailed individually, data were
collected over a three-week period, and reminder emails
were sent every week.
Two focus groups (n58 students) were also conduct-
ed to obtain further insights into student attitudes and
perceptions. An invitation was sent by email to all third-
year students asking for voluntary participation.
RESULTS
The students correctly answered the three back-
ground questions and were discussed at the beginning of
the workshop. The students worked collaboratively dur-
ing the workshop to answer the questions in Appendix 1.
Two focus groups (n58 students) were conducted.
One focus group consisted of three students (all female)
and the second had five students (two male and three
female). In the pilot focus group, students reported in-
creased engagement and improved learning occurred
when they enjoyed what was being taught; therefore, a
further question on this aspect was included in the final
online questionnaire. There was a 44% response rate
(n572) to the online questionnaire. All respondents in-
dicated their age was from 18 to 24 years; 21%were male
and 79% were female.
From the online questionnaire, there was complete
agreement (no student disagreed) that the case study in-
tegrated the science of warfarin to pharmacy practice, all
students agreed that they enjoyed the case study approach,
and 94% agreed that this approach helped them to under-
stand the science of warfarin more than if delivered
through a traditional lecture. “It was great because we
were able to discuss it instead of researching answers so
a better understanding was gained. Also, the style of
teaching allows participation rather in a lecture” and “I
really enjoyed the workshop. It was much more interest-
ing than most lectures.” There was a mixed response on
the structure delivery of the workshop to smaller groups
or to the entire cohort. A small number of students re-
ported that the workshop format did not allow complete
participation. Student perspectives on the integrated war-
farin case study obtained from the online questionnaire
are shown in Table 2.
The majority of student feedback from the question-
naire and focus groups was that more time should have
been given to complete the case study. Almost two-thirds
(62.5%) of students strongly agreed and 35.9% agreed
that the MPharm degree program should introduce more
case studies that incorporate science and pharmacy prac-
tice into the curriculum.
DISCUSSION
We developed a suitable framework to support the
design and structure of an integrated pharmacy case
study and assessed the implementation of an integrated
case study onwarfarin therapywithin the third year of an
MPharm degree program. Using such a contextualized
approach helps students to link their learning experience
to real world scenarios, which has been shown to in-
crease motivation.16 The integration of science and
pharmacy practice facilitates students to gain a deeper
appreciation of the different disciplines within phar-
macy and, more specifically, a greater understanding
of how they link together towards the development of
therapeutics.When we reviewed the literature for exam-
ples of case studies that integrated science and chemistry
of a medicine to pharmacy practice suitable for under-
graduate students, the extent of appropriate examples
were limited. This identified the need for a suitable
framework that could be used to shape and guide the
development of an integrated pharmacy case study.
The framework we have created may be adopted by
other schools, and the exercise using the warfarin case
study may be used as presented or amended to comple-
ment their pharmacy curricula.
Warfarin therapy was chosen as a central therapeutic
area because of its prevalence in pharmacy practice and
the importance for pharmacy students to understand the
CYP enzymes systems and associated pharmacokinetics.
Warfarin is metabolized primarily via oxidation in the
liver by CYP2C9. Polymorphism in the CYP family and
particularly CYP2D6, 2C19, and 2C9 polymorphisms ac-
count for the most frequent variations in phase 1 meta-
bolism of drugs as these specific enzymes are involved in
the metabolism of up to 80% of drugs used today.25 It is
critical that pharmacy students understand the implica-
tions of polymorphism, the large inter-individual vari-
ability in drug clearance, half-life, and adverse drug
reactions and responses in clinical practice. Creating
suitable learning activities that allow students to revisit
important concepts throughout the entire curriculum,
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increasing the complexity with each visit, is a strategy
advocated for the design of a spiral curriculum that allows
the situation of a new learning experience within the con-
text of a previous learning experience.26
All students agreed that they enjoyed the case study
approach, and 94% agreed that this approach helped them
to understand the science of warfarin more than if deliv-
ered through a traditional lecture. This active learning
approach supports student engagement. A study on the
effect of integrated teaching with case-based learning
(CBL) for biochemistry in an undergraduate medical pro-
gram found that the performance of students in terms
of clinical knowledge on an innovative CBL curriculum
significantly improved (p,.001) compared to a more tra-
ditional, lecture-based curriculum.27 Similar to our inte-
grated case study approach, there was much positive
student feedback related to the valuable exchange of ideas
in the CBL approach, and the majority of students con-
sidered their understanding of the subject to be better and
helpful in terms of their future application of knowledge.
The inclusion of learning objectives in the case
study was highlighted as positive for learning. “It was
very good that the questions in the case study were linked
to learning objectives. So not only dowe knowwhatwe’re
learning, but also how to apply that knowledge and then
know what’s required of us.” There were mixed views on
the delivery format of the workshop to smaller groups or
to the entire cohort. We had identified the benefit of
smaller groups for increased interactivity, but because
of practical constraints, we were unable to achieve this.
Student comments included, “It was a good learning ex-
perience but would have loved to be in smaller groups.”
Interesting insights into student perceptions of smaller
groups sizes and missing key discussion points in differ-
ent groups were highlighted in the student evaluations.
Some students feel inhibited to speak up in a large group
and smaller groups would provide a safer learning envi-
ronment. There were also concerns from some students
about missing discussion points from other smaller work-
shops and how everyone in a lecture hears the same con-
sistent message.
The time allocated to the workshop was also a con-
cern in the planning phase.Wewere not surprised that the
majority of student feedback indicated that more time
should have been available. “I think there wasn’t enough
time to go through all the questions. Even though we did
get the answers put up on the site later you still don’t get
the same level of comprehension as you would have if
we’d been able to go through all the questions in the
workshop.”












I enjoyed the case study approach used in the workshop. 68 50 50 0 0
The case study approach helped me to understand the science
more than if it were a traditional lecture.
66 40.6 53.1 6.3 0
The questions that were asked addressed the GPhC learning
outcomes mentioned at the beginning of the case study.
65 26.6 73.4 0 0
The case study integrated the science of warfarin and how
this links to pharmacy practice.
65 45.3 54.7 0 0
The learning outcomes at the beginning were useful
and necessary.
65 31.3 65.6 3.1 0
The table at the end is a useful summary tool that could be
used for drugs other than warfarin.
64 43.8 56.2 0 0
I would have preferred to prepare all the questions prior to the
workshop and work through them together with the
lecturer.
64 28.1 43.8 28.1 0
I would have preferred the workshop to be in groups rather
than as the whole year.
64 26.6 26.6 40.6 6.2
The link between the science and pharmacy practice of
warfarin was not clear.
64 0 3.1 64.1 32.8
The time allowed for the workshop was sufficient. 64 6.3 39.1 43.8 10.8
The MPharm degree program should introduce more case
studies that incorporate science and pharmacy practice into
the curriculum.
64 62.5 35.9 1.6 0
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Almost two-thirds (62.5%) of the students strongly
agreed that the MPharm degree program should intro-
duce more case studies that incorporate science
and pharmacy practice into the curriculum. Student
feedback also supported this strategy: “these kind of
case studies should more appear duringMPharm course.
Students must have the chance to discuss and learn
about different case studies about a range of illnesses
and conditions.”
The three-step integrated model was a successful
scaffolding approach to support the integration of sci-
ence and pharmacy practice and made explicit links be-
tween the fundamental science and clinical aspects for
students. One student said, “It was interesting to see the
link betweenwhy a patientmight get side effects or other
disorders as a result of warfarin explained through
the science of how it works rather than just listing side
effects.” Another stated that “because the structure of
VitaminK is similar to warfarin, but you didn’t know the
drug was warfarin, you could figure out how it works.”
The three-step integrated model used can be incorpo-
rated to support teaching activities for other clinical
drugs.
The instructors involved in the development of the
integrated model considered it extremely useful in terms
of the contextualisation of chemistry and pharmacology
into a clinical situation. A limitation of this report is that
themodel has been developed in a single institutionwith a
relatively small cohort of students. The evaluations in-
clude the student perceptions using this approach in a
teaching session and future work is needed to fully ana-
lyse the impact of an integrated case study approach on
student learning outcomes.
The potential future application of the framework
could provide a student-centered approach for final year
MPharm students to create and develop their own case
studies.
We believe the framework provided here further
supports an independent, deep-learning approach
that enables pharmacy students to stretch their appli-
cation of concepts, implementing their own case study
design, considering key components outlined in the
framework.
CONCLUSION
A framework to support the integration of science,
pharmacology, and pharmacy practicewas developed and
used to successfully design and implement an integrated
case study focusing on warfarin therapy. Pharmacy stu-
dents found the activity enjoyable and felt that this ap-
proach better supported their learning. Other pharmacy
educators should consider using this approach of
integrating case studies within clinical pharmacy educa-
tion to help contextualize pharmaceutical chemistry and
pharmacology.
REFERENCES
1. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of
warfarin and its drug and food interactions. Archives of Internal
Medicine. 2005;165(10):1095-1106.
2. General Pharmaceutical Council. Future pharmacists: standards
for the initial education and training of pharmacists. 2011; https://
www.pharmacyregulation.org/education/education-standards.
Accessed June 6, 2017.
3. Center for the Advancement of Pharmacy Education.
CAPE Educational Outcomes. 2013; http://www.aacp.org/
resources/education/cape/Pages/default.aspx. Accessed June 6,
2017.
4. Accreditation Council for Pharmacy Education. Accreditation
Standards and Key Elements for the Professional Program in
Pharmacy leading to the Doctor of Pharmacy Degree. 2015; https://
www.acpe-accredit.org/pdf/Standards2016FINAL.pdf. Accessed
June 6, 2017.
5. Ratka A. Integration as a paramount educational strategy in
academic pharmacy. Am J Pharm Educ. 2012;76(2):Article 19.
6. Pearson M, Hubball H. Curricular integration in pharmacy
education. Am J Pharm Educ. 2012;76(10):Article 204.
7. Harden RM. The integration ladder: a tool for curriculum planning
and evaluation. Med Educ. 2000;34(7):551-557.
8. Marriott J, Styles K, McDowell J. The Pharmville community: a
curriculum resource platform integrating context and theory. Am J
Pharm Educ. 2012;76(9):Article 178.
9. Kullgren J, Radhakrishnan R, Unni E, Hanson E. An integrated
course in pain management and palliative care bridging the basic
sciences and pharmacy practice. Am J Pharm Educ. 2013;
77(6):Article 121.
10. Nelson M, Dean Allison S, McCollum M, et al. The Regis Model
for pharmacy education: a highly integrated curriculum delivered by
Team-Based Learning (TBL). Curr Pharm Teach Learn. 2013;5:555-
563.
11. Richardson A, Curtis ADM, Moss GP, et al. Simulated drug
discovery process to conduct a synoptic assessment of pharmacy
students. Am J Pharm Educ. 2014;78(2):Article 41.
12. Marshall LL, Nykamp D. Active-learning assignments to
integrate basic science and clinical course material. Am J Pharm
Educ. 2010;24(7):Article 119.
13. Pierce R, Fox J. Vodcasts and active-learning exercises in a
“flipped classroom” model of a renal pharmacotherapy module. Am J
Pharm Educ. 2012;76(10):Article 196.
14. Ives TJ, Deloatch KH, Ishaq KS. Integration of medicinal
chemistry and pharmacotherapeutics courses: a case-based, learner-
centered approach. Am J Pharm Educ. 1998;62:406-411.
15. Lohman, M. Cultivating problem-solving skills through
problem-based approaches to professional development. Human
Resource Development Quarterly. 2002;13(3):243-261.
16. Bennett J, Lubben F, Hogarth S. Bringing science to life: a
synthesis of the research evidence on the effects of context-based and
STS approaches to science teaching. Science Education.
2007;91:347-370.
17. Currie BL, Chapman RL, Christoff JJ, Sikorski L. Patient related
case studies in medicinal chemistry. Am J Pharm Educ. 1994;58:446-
450.
American Journal of Pharmaceutical Education 2019; 83 (5) Article 6688.
780
18. Roche VF. Antihyperlipidemic statins: a self-contained,
clinically relevant medicinal chemistry lesson. Am J Pharm Educ.
2005;69(4):Article 77.
19. Linkins L, Choi P, Douketis J. Clinical impact of bleeding in
patients taking oral anticoagulant therapy for venous
thromboembolism. Ann Intern Med. 2013;139:893-900.
20. Palkimas Jr MP, Skinner HM, Gandhi PJ, Gardner AJ.
Polymorphism induced sensitivity to warfarin: a review of
the literature. J Thrombosis Thrombolysis. 2003;15(3):
205-212.
21. Baxter K, ed. Stockley’s Drug Interactions: A Source Book of
Interactions, Their Mechanisms, Clinical Importance and
Management. London: Pharmaceutical Press; 2010:438-439.
22. Johnstone AH, Al-Naeme FF. Room for scientific thought? Int J
Sci Educ. 1991;13:187-192.
23. Miller GE. The assessment of clinical skills/competence/
performance. Acad Med. 1990;65(9):563-567.
24. Krathwohl DR. A revision of Bloom’s taxonomy: an overview.
Theory into Practice. 2002;41(4):212-218.
25. Zhou SF, Liu JP, Chowbay B. Polymorphism of human
cytochrome P450 enzymes and its clinical impact. Drug Metabolism
Reviews. 2009;41(2):89-295.
26. Harden RM. What is a spiral curriculum? Medical Teacher.
1999;21(2):141-143.
27. Surapaneni KM. The effect of integrated teaching with case
based learning (CBL) in the biochemistry of undergraduate medical
curriculum. J Clin Diagn Res. 2010;5:3058-3063.
28. Francis SA, Smith F, Malkinson J, Constanti A, Taylor K.
Integrated Pharmacy Case Studies. London: Pharmaceutical Press;
2015.
American Journal of Pharmaceutical Education 2019; 83 (5) Article 6688.
781
Appendix 1. Additional Questions on the Warfarin Case Study
1. A. Vitamin K is required for the blood to clot. Considering the structures of both warfarin and Vitamin K, what could you
suggest as the mechanism of action for warfarin?
B. Therefore, describe how Vitamin K would affect anticoagulation therapy with warfarin
C. i) Considering your answers to 1A and 1B, describe what you think could have contributed to Patient AB’s “uncontrolled
anticoagulation therapy”
ii) What would you advise him based on the above information?
2. A. i) Warfarin is administered as sodium salt. Why is this important for oral absorption?
ii) How is salt formation possible when no carboxylic acid functional group is present in warfarin?
B. Once a tablet is taken and absorbed, how is the effect of warfarin monitored?
C. i) How is a Pharmacist involved in the monitoring of warfarin for a patient?
ii) Considering your answer to 2Ci), what advice would you give to Patient AB?
3. A. Warfarin is administered as a racemate drug. Explain from its chemical structure how warfarin is a racemate.
B. The two enantiomers that make up the warfarin racemate are both metabolized by the Cytochrome P450 (CYP) enzyme
system. By knowing the enzyme system involved in the metabolism of warfarin, what must a Pharmacist ensure if a patient
needs to take another medication?
C. i) Considering your answers to 3A and 3B, what does this indicate about warfarin?
ii) Therefore, explain the reason for Patient AB’s “uncontrolled anticoagulation therapy” and symptoms.
4. A. i) S-warfarin and R-warfarin have the same molecular formula but differ in the spatial arrangements of their functional
groups. Would you expect them both to have the same pharmacodynamic activities and pharmacokinetic properties?
ii) Explain why.
B. Some drugs can interact stereo-specifically with warfarin. When a drug interacts with R-warfarin, it would cause a minor
increase in the anticoagulant effect of warfarin. However, when a drug interacts with S-warfarin, it would cause a major
increase in anticoagulant effect of warfarin. What does this suggest about S-warfarin compared to R-warfarin?
C. Considering your answers to 4A and 4B, and the alarming symptoms Patient AB is experiencing, what does this tell you
about the interaction between Metronidazole and warfarin?
5. A. By summarising all of the above, what advice would you give Patient AB?
B. How could you ensure patient safety for AB in the future?
C. As a quick summary, complete the table below for each scientific concept involved in this case study.
Scientific Concept How this relates to pharmacy practice How this leads to medicines optimization for Patient AB
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Appendix 2. Questionnaire
Please indicate your age group: 18-24___ 25-34 ___ 35-44 ___ 45 or over___






I enjoyed the case study approach used in the workshop.
The case study approach helped me to understand the science more than if it were a
traditional lecture.
The questions that were asked addressed the learning outcomes discussed at the
beginning of the case study.
The case study integrated the science of warfarin and how this links to pharmacy practice.
The learning outcomes at the beginning of the workshop were useful and necessary.
The table at the end is a useful summary tool that could be used for drugs other than
warfarin.
I would have preferred to prepare all the questions prior to the workshop and work
through them together with the lecturer.
I would have preferred the workshop to be in groups rather than as the whole year.
The link between the science and pharmacy practice of warfarin was not clear.
The time allowed for the workshop was sufficient.
The MPharm degree program should introduce more case studies that incorporate science
and pharmacy practice into the curriculum.
Please state (if not already) your overall opinion of the case study workshop, including
any comments, concerns, particular strengths or weaknesses.
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